You are here:
14.01.2021
Video: conversation with Prof. Stefan Fröhling
From gene to therapy: individually adapted cancer medicine
Stefan Fröhling is Managing Director at NCT Heidelberg and Head of the Translational Medical Oncology Division at the German Cancer Research Center (DKFZ). He works at the interface between clinical patient care in oncology and experimental tumor research. In an interview he talks about the topic "From gene to therapy: individually adapted cancer medicine.
Latest News

02.11.2026
November 11, 2026: Highlights of the Annual Meeting of the European Society for Medical Oncology (ESMO)

26.10.2026
Daraxonrasib for Pancreatic Cancer: Experts and Study Participants from the NCT Heidelberg in the Media

20.10.2026